Page last updated: 2024-08-21

thiazoles and Depressive Disorder, Major

thiazoles has been researched along with Depressive Disorder, Major in 46 studies

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	23 (50.00)	29.6817
2010's	21 (45.65)	24.3611
2020's	2 (4.35)	2.80

Authors

Authors	Studies
Panczyszyn-Trzewik, P; Rzezniczek X, S; Sowa-Kucma, M; Stachowicz, K	1
Han, J; Huang, M; Luo, L; Ma, X; Shi, H; Su, C; Wang, A; Wang, H; Wang, W; Wu, K; Xu, T; Xu, X; Yuan, T	1
Grabe, HJ; Janowitz, D; Schomerus, G; Speerforck, S	1
Hetrick, SE; Loy, JH; Merry, SN; Stasiak, K	1
Carvalho, AF; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E; Young, AH	1
Baer, L; Cardoos, A; Clain, A; DiPierro, M; Doorley, J; Fava, M; Jeon, HJ; Mischoulon, D; Papakostas, GI	1
Citrome, L	1
Caravaggio, F; Chung, JK; Fervaha, G; Gerretsen, P; Graff-Guerrero, A; Iwata, Y; Mihashi, Y; Mulsant, B; Nakajima, S; Plitman, E; Remington, G; Takeuchi, H	1
Cucchiaro, J; Kroger, H; Loebel, A; McIntyre, RS; Pikalov, A	1
Baer, L; Bobo, WV; Fava, M; Jaeger, A; Papakostas, GI; Shelton, RC; Swee, MB	1
Nelson, JC	1
Baer, L; Fava, M; Ionescu, DF; Meade, KH; Papakostas, GI; Shelton, RC; Swee, MB	1
Baer, L; Bobo, WV; Curren, L; Fava, M; Mischoulon, D; Papakostas, GI; Shelton, RC	1
Lee, Y; Mansur, RB; McIntyre, RS	1
Kaneko, S; Nakagami, T; Saito, M; Sato, Y; Yasui-Furukori, N	1
Akhtar, J; Dunner, D; Johnson, AE; Liebowitz, MR; Mech, A; Pratap, R; Salmán, E	1
Florakis, A; Markatou, M; Masdrakis, VG; Oulis, P; Tzanoulinos, G	1
Gitlin, MJ; Rim, CL	1
Dadić-Hero, E; Grahovac, T; Knez, R; Kosec, T; Ružić, K; Sabljić, V	1
Chappell, PB; Gurtovaya, O; Ice, KS; Kasuba, B; Sachs, GS; Schwartz, JH; Vanderburg, DG	1
Alvarez, E; Artigas, F; Celada, P; Cortés, R; Lladó-Pelfort, L; Oller, S; Pérez, V; Pérez-Egea, R; Portella, MJ; Puigdemont, D; Scorza, MC	1
Filkowski, MM; Ghaemi, SN; Gilmer, W; Holtzman, NS; Loebel, A; Logvinenko, T; Masand, P; Mulligan, M; Pae, CU; Patkar, A; Pirok, E; Thommi, SB; Vöhringer, PA; Whitham, EA; Ziffra, M	1
Li, RM; Liu, ZW; Wang, C; Zhao, B	1
Abrams, J; Bari, MA; Fava, M; Hails, KA; Ishak, WW; Kinrys, G; Lipkin, SH; Meisner, A; Mischoulon, D; Okasha, MS; Papakostas, GI; Rapaport, MH; Schoenfeld, DA; Shelton, RC; Vitolo, OV; Ward, SG; Winokur, A; Zajecka, JM	1
Abelli, M; Bassi, A; Battistini, G; Cassano, GB; Cassano, P; Dell'Osso, L; Gemignani, A; Houck, PR; Lattanzi, L; Pini, S; Rucci, P	1
Biswas, AK; Mayes, KL; Morris-Kukoski, CL; Zabrocki, LA	1
Binder, EB; Holsboer, F; Keck, ME; Müller, MB; Sonntag, A	1
Burdick, KE; Endick, CJ; Goldberg, JF	1
Alpert, JE; Fava, M; Murakami, JL; Nierenberg, AA; Papakostas, GI; Petersen, TJ; Rosenbaum, JF	1
Ravasia, S; Swensen, E	1
Battistini, G; Cassano, GB; Cassano, P; Gemignani, A; Lattanzi, L; Navari, S; Soldani, F	1
Bares, M; Kopecek, M; Mohr, P	1
Khan, A; Preskorn, S; Ramadan, M	1
Frank, B; Gupta, S; Vincent, JL	1
Cannon, DM; Carson, RE; Drevets, M; Drevets, WC; Eckelman, WC; Gandhi, S; Kiesewetter, DO; Nugent, AC; Rollis, D; Solorio, G; Williams, J	1
Amsterdam, JD; Dunner, DL; Loebel, A; Romano, SJ; Shelton, RC	1
Chua, SE; Chung, AK	1
Papakostas, GI; Shelton, RC	1
Carpenter, LL; Philip, NS; Price, LH; Tyrka, AR	1
Alvarez, E; Pascual, JC; Pérez, V; Pérez-Egea, R; Puigdemont, D; Soler, J; Tiana, T	1
Breen, JA; DeBattista, C; Schatzberg, AF; Solvason, HB	1
Corrigan, MH; Denahan, AQ; Evans, DL; Ragual, RJ; Wright, CE	1
Weizman, A; Weizman, R	1
Davis, R; Risch, SC	1
Crismon, L; Dorson, PG; Patel, NC; Sierk, P	1

Reviews

7 review(s) available for thiazoles and Depressive Disorder, Major

Article	Year
Atypical antipsychotics for disruptive behaviour disorders in children and youths. The Cochrane database of systematic reviews, 2017, 08-09, Volume: 8 Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Conduct Disorder; Depressive Disorder, Major; Dibenzothiazepines; Humans; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Weight Gain	2017
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines. Acta psychiatrica Scandinavica, 2018, Volume: 138, Issue:3 Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Thiazoles; Valproic Acid	2018
Treatment of bipolar depression: making sensible decisions. CNS spectrums, 2014, Volume: 19 Suppl 1 Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Dibenzothiazepines; Drug Combinations; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lithium Compounds; Lurasidone Hydrochloride; Quetiapine Fumarate; Thiazoles; Valproic Acid	2014
A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disorders. CNS spectrums, 2016, Volume: 21, Issue:S1 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cognitive Behavioral Therapy; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium Compounds; Mood Disorders; Piperazines; Thiazoles	2016
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Acta psychiatrica Scandinavica, 2008, Volume: 117, Issue:4 Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles	2008
Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. Journal of psychiatric practice, 2008, Volume: 14, Issue:1 Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Depressive Disorder, Major; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles	2008
Use of atypical antipsychotics in mood disorders. Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:7 Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Depressive Disorder, Major; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles	2001

Trials

19 trial(s) available for thiazoles and Depressive Disorder, Major

Article	Year
Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with major depressive disorder: a 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial. International clinical psychopharmacology, 2014, Volume: 29, Issue:6 Topics: Adult; Antipsychotic Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Thiazoles; Treatment Outcome	2014
Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data. Schizophrenia research, 2015, Volume: 161, Issue:2-3 Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Depressive Disorder, Major; Double-Blind Method; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2015
Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:4 Topics: Adult; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Thiazoles	2015
Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study. The American journal of psychiatry, 2015, Volume: 172, Issue:12 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles; Treatment Outcome	2015
Ziprasidone augmentation for anxious depression. International clinical psychopharmacology, 2016, Volume: 31, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles; Young Adult	2016
Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study. The Journal of clinical psychiatry, 2017, Volume: 78, Issue:4 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Electrocardiography; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiazoles; Weight Gain; Young Adult	2017
Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Apr-30, Volume: 33, Issue:3 Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder, Major; Drug Synergism; Female; Humans; Isoindoles; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Retrospective Studies; Thiazoles; Time Factors	2009
Ziprasidone monotherapy in bipolar II depression: an open trial. Journal of affective disorders, 2009, Volume: 118, Issue:1-3 Topics: Adult; Affect; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Interview, Psychological; Male; Middle Aged; Personality Inventory; Piperazines; Psychometrics; Thiazoles; Treatment Outcome	2009
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:10 Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium; Male; Middle Aged; Piperazines; Serotonin Antagonists; Thiazoles; Treatment Outcome; Triazines; Valproic Acid; Young Adult	2011
Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. British journal of pharmacology, 2012, Volume: 167, Issue:5 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adult; Animals; Antidepressive Agents; Brain; Depressive Disorder, Major; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Piperazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles	2012
A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. PloS one, 2012, Volume: 7, Issue:4 Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles; Treatment Outcome	2012
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:12 Topics: Adult; Antipsychotic Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Psychometrics; Thiazoles	2012
Pramipexole in treatment-resistant depression: a 16-week naturalistic study. Bipolar disorders, 2002, Volume: 4, Issue:5 Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Benzothiazoles; Combined Modality Therapy; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Thiazoles	2002
Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. The American journal of psychiatry, 2004, Volume: 161, Issue:3 Topics: Adult; Ambulatory Care; Anticonvulsants; Antimanic Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Pilot Projects; Pramipexole; Thiazoles	2004
Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:2 Topics: Adult; Antipsychotic Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Piperazines; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Thiazoles; Treatment Outcome	2004
Pramipexole in treatment-resistant depression: an extended follow-up. Depression and anxiety, 2004, Volume: 20, Issue:3 Topics: Acute Disease; Adult; Aged; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Surveys and Questionnaires; Thiazoles; Treatment Outcome	2004
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:7 Topics: Adult; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline; Thiazoles; Treatment Outcome	2007
Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Humans; Middle Aged; Neurocognitive Disorders; Piperazines; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders; Surveys and Questionnaires; Thiazoles	2008
Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depression and anxiety, 2000, Volume: 11, Issue:2 Topics: Adult; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Assessment; Pramipexole; Selective Serotonin Reuptake Inhibitors; Thiazoles	2000

Other Studies

20 other study(ies) available for thiazoles and Depressive Disorder, Major

Article	Year
Cyclooxygenase-2 inhibition affects the expression of down syndrom cell adhesion molecule via interaction with metabotropic glutamate receptor 5. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2022, Volume: 73, Issue:2 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arachidonic Acid; Cell Adhesion; Cell Adhesion Molecules; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Depressive Disorder, Major; Imipramine; Mice; Mice, Inbred C57BL; Nitrobenzenes; Pyridines; Receptor, Metabotropic Glutamate 5; RNA, Messenger; Sulfonamides; Thiazoles	2022
mGluR5-Mediated eCB Signaling in the Nucleus Accumbens Controls Vulnerability to Depressive-Like Behaviors and Pain After Chronic Social Defeat Stress. Molecular neurobiology, 2021, Volume: 58, Issue:10 Topics: Animals; Cannabinoid Receptor Antagonists; Chronic Disease; Depressive Disorder, Major; Endocannabinoids; Male; Mice; Mice, Inbred C57BL; Microinjections; Nucleus Accumbens; Pain; Piperidines; Pyrazoles; Pyridines; Receptor, Metabotropic Glutamate 5; Signal Transduction; Social Defeat; Stress, Psychological; Thiazoles	2021
[Psychosis, Intoxication or Serotonin Syndrome? - A 20-Year Old Male with Ziprasidone und Sertraline]. Psychiatrische Praxis, 2017, Volume: 44, Issue:8 Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lorazepam; Male; Piperazines; Psychotropic Drugs; Schizophrenia, Paranoid; Schizophrenic Psychology; Serotonin Syndrome; Sertraline; Substance-Related Disorders; Thiazoles; Young Adult	2017
Adjunctive Ziprasidone in Major Depression and the Current Status of Adjunctive Atypical Antipsychotics. The American journal of psychiatry, 2015, Volume: 172, Issue:12 Topics: Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Piperazines; Thiazoles	2015
ADDENDUM. The American journal of psychiatry, 2015, Volume: 172, Issue:12 Topics: Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Piperazines; Thiazoles	2015
Safety of the electroconvulsive therapy-ziprasidone combination. The journal of ECT, 2010, Volume: 26, Issue:2 Topics: Adult; Antipsychotic Agents; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Middle Aged; Piperazines; Thiazoles	2010
Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:4 Topics: Adult; Depressive Disorder, Major; Drug Interactions; Female; Humans; Monoamine Oxidase Inhibitors; Piperazines; Serotonin Antagonists; Serotonin Syndrome; Thiazoles; Tranylcypromine	2010
Switching among antipsychotics--focus on side effects. Psychiatria Danubina, 2011, Volume: 23, Issue:1 Topics: Affective Disorders, Psychotic; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Eruptions; Drug Substitution; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Piperazines; Pruritus; Sulpiride; Thiazoles; Weight Gain	2011
A case of severe hyponatremia induced by duloxetine and ziprasidone. Chinese medical journal, 2012, Volume: 125, Issue:20 Topics: Antidepressive Agents; Antipsychotic Agents; Creatine Kinase; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Middle Aged; Piperazines; Thiazoles; Thiophenes	2012
Cardiotoxicity associated with intentional ziprasidone and bupropion overdose. Journal of toxicology. Clinical toxicology, 2003, Volume: 41, Issue:2 Topics: Adolescent; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Consciousness; Depressive Disorder, Major; Drug Overdose; Electrocardiography; Heart Diseases; Humans; Hydrogen-Ion Concentration; Lidocaine; Long QT Syndrome; Male; Piperazines; Suicide, Attempted; Thiazoles	2003
Ziprasidone-related tardive dyskinesia. The American journal of psychiatry, 2004, Volume: 161, Issue:1 Topics: Aged; Antipsychotic Agents; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Thiazoles	2004
Ziprasidone-induced lupus erythematosus. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:6 Topics: Depressive Disorder, Major; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Piperazines; Psychotic Disorders; Serotonin Antagonists; Thiazoles	2004
Ziprasidone-induced galactorrhea: a case report. Neuro endocrinology letters, 2005, Volume: 26, Issue:1 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Clonazepam; Depressive Disorder, Major; Female; Galactorrhea; Humans; Lithium; Piperazines; Prolactin; Recurrence; Thiazoles	2005
D2-blockade and possible ziprasidone-induced galactorrhea. International clinical psychopharmacology, 2005, Volume: 20, Issue:2 Topics: Adult; Antipsychotic Agents; Depressive Disorder, Major; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Galactorrhea; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Thiazoles	2005
Pramipexole: augmentation in the treatment of depressive symptoms. CNS spectrums, 2006, Volume: 11, Issue:3 Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Pramipexole; Somatoform Disorders; Thiazoles	2006
Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. Archives of general psychiatry, 2006, Volume: 63, Issue:7 Topics: Acetylcholine; Adult; Ambulatory Care; Bipolar Disorder; Brain; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Pyridines; Radioligand Assay; Receptor, Muscarinic M2; Synapses; Thiazoles; Tissue Distribution	2006
Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Acute Disease; Antipsychotic Agents; Depressive Disorder, Major; Drug Monitoring; Electroconvulsive Therapy; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin, 5-HT2; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Urinary Catheterization; Urinary Retention	2007
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2 Topics: Benzothiazoles; Chronic Disease; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Middle Aged; Pramipexole; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazoles	2000
Ziprasidone induction of hypomania in depression? The American journal of psychiatry, 2002, Volume: 159, Issue:4 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Piperazines; Recurrence; Thiazoles	2002
Experience with ziprasidone. Journal of the American Academy of Child and Adolescent Psychiatry, 2002, Volume: 41, Issue:5 Topics: Adolescent; Antipsychotic Agents; Contraindications; Depressive Disorder, Major; Drug Evaluation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Thiazoles	2002